The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation

INTRODUCTION: The treatment of septic conditions in critically ill patients is still one of medicine's major challenges. Cyclic nucleotides, adenosine and its receptors play a pivotal role in the regulation of inflammatory responses and in limiting inflammatory tissue destruction. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayhan, Nalan, Funke, Benjamin, Conzelmann, Lars Oliver, Winkler, Harald, Hofer, Stefan, Steppan, Jochen, Schmidt, Heinfried, Bardenheuer, Hubert, Vahl, Christian-Friedrich, Weigand, Markus A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592762/
https://www.ncbi.nlm.nih.gov/pubmed/18847498
http://dx.doi.org/10.1186/cc7033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592762/
https://www.ncbi.nlm.nih.gov/pubmed/18847498
http://dx.doi.org/10.1186/cc7033

Ejemplares similares